Literature DB >> 14288990

USE OF AN ORAL CORTICOSTEROID IN THE TREATMENT OF MULTIPLE SCLEROSIS; A DOUBLE-BLIND STUDY.

W W TOURTELLOTTE, A F HAERER.   

Abstract

Entities:  

Keywords:  CLINICAL RESEARCH; DRUG THERAPY; METHYLPREDNISOLONE; MULTIPLE SCLEROSIS; VITAMIN B 12

Mesh：

Substances：

Year:  1965        PMID： 14288990     DOI： 10.1001/archneur.1965.00460290092010

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


× No keyword cloud information.
  6 in total

1.  A battery of tests for evaluating steadiness in clinical trials.

Authors:  A R Potvin; J W Albers; R F Stribley; W W Tourtellotte; R W Pew
Journal:  Med Biol Eng       Date:  1975-11

Review 2.  Corticosteroids and plasma exchange in multiple sclerosis.

Authors:  Hayretin Tumani
Journal:  J Neurol       Date:  2008-12       Impact factor: 4.849

3.  Immunological treatment of multiple sclerosis.

Authors:  R A Hughes
Journal:  J Neurol       Date:  1983       Impact factor: 4.849

4.  A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects.

Authors:  N M Milligan; R Newcombe; D A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-05       Impact factor: 10.154

5.  "Bolus" methylprednisolone versus ACTH in the treatment of multiple sclerosis.

Authors:  G Abbruzzese; C Gandolfo; C Loeb
Journal:  Ital J Neurol Sci       Date:  1983-06

Review 6.  Multiple sclerosis.

Authors:  S G Lynch; J W Rose
Journal:  Dis Mon       Date:  1996-01       Impact factor: 3.800
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.